Authorities halt use of problematic products after fourth baby death

Guangdong has purchased 1.45 million doses of hepatitis B vaccine for the province after health authorities halted the use of a vaccine suspected in the deaths of four babies.

A baby boy in Shenzhen died on Tuesday after being inoculated with hepatitis B vaccine produced by Biokangtai, a local pharmaceutical company.